Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment.
Araujo AM, Abaurrea A, Azcoaga P, López-Velazco JI, Manzano S, Rodriguez J, Rezola R, Egia-Mendikute L, Valdés-Mora F, Flores JM, Jenkins L, Pulido L, Osorio-Querejeta I, Fernández-Nogueira P, Ferrari N, Viera C, Martín-Martín N, Tzankov A, Eppenberger-Castori S, Alvarez-Lopez I, Urruticoechea A, Bragado P, Coleman N, Palazón A, Carracedo A, Gallego-Ortega D, Calvo F, Isacke CM, Caffarel MM, Lawrie CH. Araujo AM, et al. Among authors: isacke cm. J Clin Invest. 2022 Oct 3;132(19):e165107. doi: 10.1172/JCI165107. J Clin Invest. 2022. PMID: 36169029 Free PMC article. No abstract available.
Endo180 (MRC2) Antibody-Drug Conjugate for the Treatment of Sarcoma.
Evans RJ, Perkins DW, Selfe J, Kelsey A, Birch GP, Shipley JM, Schipper K, Isacke CM. Evans RJ, et al. Among authors: isacke cm. Mol Cancer Ther. 2023 Feb 1;22(2):240-253. doi: 10.1158/1535-7163.MCT-22-0312. Mol Cancer Ther. 2023. PMID: 36399638 Free PMC article.
Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment.
Araujo AM, Abaurrea A, Azcoaga P, López-Velazco JI, Manzano S, Rodriguez J, Rezola R, Egia-Mendikute L, Valdés-Mora F, Flores JM, Jenkins L, Pulido L, Osorio-Querejeta I, Fernández-Nogueira P, Ferrari N, Viera C, Martín-Martín N, Tzankov A, Eppenberger-Castori S, Alvarez-Lopez I, Urruticoechea A, Bragado P, Coleman N, Palazón A, Carracedo A, Gallego-Ortega D, Calvo F, Isacke CM, Caffarel MM, Lawrie CH. Araujo AM, et al. Among authors: isacke cm. J Clin Invest. 2022 Apr 1;132(7):e148667. doi: 10.1172/JCI148667. J Clin Invest. 2022. PMID: 35192545 Free PMC article.
The anatomy of fluid-yielding ducts in breast cancer.
Twelves D, Nerurkar A, Osin P, Ward A, Isacke CM, Gui GP. Twelves D, et al. Among authors: isacke cm. Breast Cancer Res Treat. 2012 Apr;132(2):555-64. doi: 10.1007/s10549-011-1623-y. Epub 2011 Jun 15. Breast Cancer Res Treat. 2012. PMID: 21674221
DNA promoter hypermethylation profiles in breast duct fluid.
Twelves D, Nerurkar A, Osin P, Dexter T, Ward A, Gui GP, Isacke CM. Twelves D, et al. Among authors: isacke cm. Breast Cancer Res Treat. 2013 Jun;139(2):341-50. doi: 10.1007/s10549-013-2544-8. Epub 2013 May 15. Breast Cancer Res Treat. 2013. PMID: 23674191
CD44 increases the efficiency of distant metastasis of breast cancer.
McFarlane S, Coulter JA, Tibbits P, O'Grady A, McFarlane C, Montgomery N, Hill A, McCarthy HO, Young LS, Kay EW, Isacke CM, Waugh DJ. McFarlane S, et al. Among authors: isacke cm. Oncotarget. 2015 May 10;6(13):11465-76. doi: 10.18632/oncotarget.3410. Oncotarget. 2015. PMID: 25888636 Free PMC article.
140 results